PRESS RELEASES

McLean Hospital Researchers Receive Grants to Study Fear and Schizophrenia

FOR IMMEDIATE RELEASE:
October 05, 2004

CONTACT:
Public Affairs
Adriana Bobinchock
Laura Neves
617/855-2110

Belmont, MA - The National Alliance for Research on Schizophrenia and Depression (NARSAD) recently awarded Independent Investigator grants totaling approximately $200,000 to Vadim Bolshakov, PhD, director McLean's Cellular Neurobiology Laboratory, and Deborah L. Levy, PhD, interim director for McLean's Psychology Laboratory.

Dr. Bolshakov will conduct a study on brain conditioning in rats, to better understand human anxiety disorder. His study results could lead to new brain targets for anti-anxiety medications. Dr. Levy will study relational memory in schizophrenia patients, to advance understanding of cognitive dysfunction in schizophrenia, and of the neurobiology of the disorder.

This is not the first time this year that McLean researchers have been awarded grants from NARSAD. In June, an unprecedented 13 McLean Hospital researchers were awarded NARSAD Young Investigator Awards.

"The grants given by NARSAD to support the work of our researchers are quite prestigious, and are a testament to the caliber of our research program and the importance of their research," said Peter Paskevich, vice president of Research Administration for McLean Hospital.

McLean Hospital maintains the largest research program of any private, U.S. psychiatric hospital. It is the largest psychiatric teaching facility of Harvard Medical School, an affiliate of Massachusetts General Hospital and a member of Partners HealthCare.

NARSAD is a nonprofit charitable organization that raises funds from individuals, corporations and foundations. It does not accept government funding. Since its founding in 1987, NARSAD has raised more than $162.1 million.

Email this page